This is the first Nordic NECT Course for Early Phase Clinical Trials in Oncology. Helsinki University Hospital will be hosting this course, the first of a possible annual event. For your reference a Nordic Course in Clinical Trials Methodology in Oncology has previously been arranged 6 times, lastly in 2014.

Early clinical trials play a crucial role in drug development. They are in an essential interface between experimental laboratory knowledge and clinical application in patients and include administration of an investigational product to humans first time (“first in human” trials). Early clinical trials require tight adherence to protocol requirements and careful monitoring of patient safety. The field is highly competitive and the requirements for the staff not only include patient care but also maintenance of strict timelines, fast site initiation and patient recruitment, top quality data entry, keeping patient safety always as the priority. Overall, they require resources, dedicated staff and coordination skills.

These and many other issues will be discussed during the course. The aim of the course is to increase participant’s knowledge in early clinical trial methodology and also strengthen important collaborations in research and network-building between the Nordic countries. The language in the course will be English.

For more informartion, please find Invitation letter including programme and link to application 

Last day of application is March 5th, 2019.

The application deadline has been expanded to Monday March 11.

The time for response on participation will be delayed to March 17th. 

Nordic NECT members meeting

March 27, 2019 in Bergen 


Nordic NECT members meeting

November 01, 2018 at Herlev 


Nordic NECT members meeting

April 05, 2018 in Oslo


Nordic NECT members meeting

November 01, 2017 in Stockholm


6th Conference on Clinical Trials in the Nordic Countries

Time and Place
25.–26.10.2017 Team Finland House, Porkkalankatu 1 (Auditorium),
Helsinki, Finland

• Update on EU Clinical Trial Regulation – Implementation Acts and Publication
• The Latest News on Development of the Clinical Trial Portal – Tester’s Experiences
• Nordic Regulatory Authority Update on the National Activities Related to the EU Regulations
• The Nordic Authority Expectations of a Successful Clinical Trial Application
• Impact of the Regulatory Changes on the Clinical Data Expectations in Europe
• Clinical Trials with Medical Devices and Combination Products
• Big Pharma View on Clinical Trials in the Nordic Region and Vision of Future Drug Development


Nordic Model for Personalized Medicine

The foremost experts in the field of personalized medicine will come together with the Nordic hospital directors and medical faculty deans to explore issues such as data sharing, privacy, innovation, stakeholder engagement, and cross-border studies from an interdisciplinary perspective.

Time and place: Nordic Model for Personalized Medicine May 19, 2017 9:00 AM - 16:00 PM, Oslo Cancer Cluster Innovation Park

Add to calendar

The aim is to bring the Nordic countries a step closer to a collaborative model for personalized medicine that utilizes the medical and technological advances to the fullest, in an ethically robust, legally compliant and societally responsible manner.

The conference is free of charge and now open for registration. To save a seat make a registration today.

We hope to see you in Parallel Session 2: Cross Border Patient for Clinical Trials, part 1 and 2.

More information, including registration and full program, on the web page of the Nordic Health Research and Innovation Networks (NRI Networks)


The conference is supported by NordForsk/Nordic Trial Alliance and UiO: Life Science